Thanks to a new technology, the diagnosis of brain cancer undergoes a breakthrough. The credit goes to cancer diagnostics company and University of Strathclyde Dxcover spin-out company. The company has indeed launched the liquid biopsy Dxcover, which was also effective in the early days of cancer growth, at a smaller volume and earlier stage.
q
There Research was published in the scientific journal Cancers.
Brain cancer: here are the advantages of the Dxcover liquid biopsy
According to Cancer Research UK, a 12,000 people in Britain are diagnosed with brain cancer each year and survival rates are 12% five years after diagnosis.
Read Also
- Weather The Coast Guard warns of heavy rains, thunderstorms and light winds, even bad heat is enough for the weekend Jul 10, 2021
- Twitter: Elon Musk announces reinstatement of suspended accounts Nov 24, 2022
- G20, Bassi (Un.Trieste): “All-Italian technology in quantum communication” Aug 5, 2021
- Instagram would offer exclusive Stories through a paid subscription | Atomix Jun 30, 2021
- World Cup 2022: Belgian Minister of Foreign Affairs appears with the armband “One Love” in front of Infantino Nov 24, 2022
- Microsoft won’t be able to buy TikTok, – ByteDance Sep 14, 2020
- Facebook wants to return to its social role: it will show less political content at the beginning Sep 1, 2021